127 related articles for article (PubMed ID: 1918089)
1. Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.
Jaffrézou JP; Herbert JM; Levade T; Gau MN; Chatelain P; Laurent G
J Biol Chem; 1991 Oct; 266(29):19858-64. PubMed ID: 1918089
[TBL] [Abstract][Full Text] [Related]
2. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
Jaffrézou JP; Levade T; Chatelain P; Laurent G
Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291
[TBL] [Abstract][Full Text] [Related]
3. The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction.
Martin C; Berridge G; Higgins CF; Callaghan R
Br J Pharmacol; 1997 Oct; 122(4):765-71. PubMed ID: 9375975
[TBL] [Abstract][Full Text] [Related]
4. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
Schmid A; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.
Jaffrézou JP; Chen KG; Durán GE; Muller C; Bordier C; Laurent G; Sikic BI; Levade T
Biochim Biophys Acta; 1995 Apr; 1266(1):1-8. PubMed ID: 7718613
[TBL] [Abstract][Full Text] [Related]
6. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line.
Abbaszadegan MR; Foley NE; Gleason-Guzman MC; Dalton WS
Int J Cancer; 1996 May; 66(4):506-14. PubMed ID: 8635866
[TBL] [Abstract][Full Text] [Related]
7. Effect of SR33557 on intramembrane charge movement in normal and 'muscular dysgenesis' mouse skeletal muscle cells.
Strube C; Shimahara T; Bournaud R
Eur J Neurosci; 1995 Jan; 7(1):41-4. PubMed ID: 7711935
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
9. Synergy between two calcium channel blockers, verapamil and fantofarone (SR33557), in reversing chloroquine resistance in Plasmodium falciparum.
Adovelande J; Delèze J; Schrével J
Biochem Pharmacol; 1998 Feb; 55(4):433-40. PubMed ID: 9514077
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
Safa AR
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
[TBL] [Abstract][Full Text] [Related]
12. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.
Safa AR; Glover CJ; Sewell JL; Meyers MB; Biedler JL; Felsted RL
J Biol Chem; 1987 Jun; 262(16):7884-8. PubMed ID: 3034908
[TBL] [Abstract][Full Text] [Related]
13. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
Greenberger LM; Yang CP; Gindin E; Horwitz SB
J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
[TBL] [Abstract][Full Text] [Related]
15. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
16. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Sachs CW; Safa AR; Harrison SD; Fine RL
J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.
McGrath T; Latoud C; Arnold ST; Safa AR; Felsted RL; Center MS
Biochem Pharmacol; 1989 Oct; 38(20):3611-9. PubMed ID: 2573357
[TBL] [Abstract][Full Text] [Related]
18. Effects of two chemically related new Ca2+ channel antagonists, SR33557 (fantofarone) and SR33805, on the L-type cardiac channel.
Romey G; Bois P; Lazdunski M
Eur J Pharmacol; 1994 Sep; 263(1-2):101-5. PubMed ID: 7821341
[TBL] [Abstract][Full Text] [Related]
19. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
20. [Calcium antagonists as modulators of multi-drug resistant tumor cells].
Hamilton G; Theyer G; Baumgartner G
Wien Med Wochenschr; 1993; 143(19-20):526-32. PubMed ID: 7907828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]